Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate

Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Suppliers list
Company Name: Shanghai Chainpharm Bio-medical Technology Co., Ltd.  
Tel: +86-021-61727342 13611721451
Email: sales@chainpharm.com
Company Name: Shanghai Synteam Biochem CO.,ltd  
Tel: +86-021-58380978 13482386415
Email: info@systeambc.com
Company Name: Cool Pharm, Ltd  
Tel: 021-60455363 18019463053
Email: sales@coolpharm.com
Company Name: ShangHai Wisacheam Pharmaceutical Co., Ltd.  
Tel: 13817485796
Email: tim@wisacheampharm.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Basic information
Product Name:Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate
Synonyms:Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate;tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5H)-...;1,6-Naphthyridine-6(2H)-carboxylic acid, 1,5,7,8-tetrahydro-2-oxo-, 1,1-dimethylethyl ester;6-Boc-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one;tert-butyl 2-hydroxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
CAS:1036381-91-5
MF:C13H18N2O3
MW:250.29
EINECS:
Product Categories:
Mol File:1036381-91-5.mol
Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Structure
Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Chemical Properties
Boiling point 470.9±45.0 °C(Predicted)
density 1.20±0.1 g/cm3(Predicted)
storage temp. 2-8°C
pka12.39±0.20(Predicted)
AppearanceWhite to off-white Solid
Safety Information
MSDS Information
Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Usage And Synthesis
Synthesis
PROPYNOIC ACID AMIDE

7341-96-0

N-(tert-Butoxycarbonyl)-4-piperidone

79099-07-3

Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate

1036381-91-5

To a stirred solution of N-Boc-4-piperidone (35.6 g, 178.89 mmol) in chloroform (260 mL) was slowly added pyrrolidine (19 mL, 223.61 mmol) dropwise over a period of 1 hour at room temperature. The reaction mixture was continued to be stirred at room temperature for 1 hour before propargylamide (16 g, 223.61 mmol) was added. Subsequently, the reaction mixture was subjected to reflux in a Dean-Stark device for 16 hours. After completion of the reaction, the mixture was cooled and filtered. The filtrate was ground with toluene and filtered again. The filtrate was concentrated under reduced pressure to give a red to brown viscous liquid. The crude product was purified by fast column chromatography (silica gel, eluent 98:2 chloroform/methanol) to yield tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5H)-carboxylate (4.01 g, 51.8% yield) as a brown oil.

References[1] Patent: WO2009/121812, 2009, A1. Location in patent: Page/Page column 75-76
Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate Preparation Products And Raw materials
Raw materialsPropynoic acid amide-->N-(tert-Butoxycarbonyl)-4-piperidone-->Pyrrolidine-->Chloroform
Preparation Products(Tert-butyl 3-bromo-2-oxo-1,5,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate)
Tag:Tert-butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5h)-carboxylate(1036381-91-5) Related Product Information
L-Tetrahydrofolic Acid 1,6-Naphthyridin-2(1H)-one,5,6,7,8-tetrahydro-(9CI) 6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one 5,6,7,8-Tetrahydro-1H-[1,6]naphthyridin-2-one hydrochloride tert-butyl 3-cyano-2-oxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-6-carboxylate (Tert-butyl 3-bromo-2-oxo-1,5,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate)